Henrik Ancher-Jensen
Corporate Officer/Principal bei AGILENT TECHNOLOGIES, INC.
Vermögen: 11 Mio $ am 30.04.2024
Aktive Positionen von Henrik Ancher-Jensen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | 01.09.2012 | - |
Karriereverlauf von Henrik Ancher-Jensen
Ehemalige bekannte Positionen von Henrik Ancher-Jensen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Geschäftsführer | 01.09.2010 | 01.09.2012 |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 | 01.09.2010 |
Ausbildung von Henrik Ancher-Jensen
University of Aarhus | Undergraduate Degree |
Statistik
International
Dänemark | 3 |
Vereinigte Staaten | 2 |
Operativ
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AGILENT TECHNOLOGIES, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |
- Börse
- Insiders
- Henrik Ancher-Jensen
- Erfahrung